Cure53 – Cybersecurity Assurance for High-Reliability Software and Systems
Independent European Capabilities in Vulnerability Research and Dual-Use Security Audits for Strategic Autonomy and Digital Resilience
14 pages · PDF · 02 February 2026 · Licensed single-user copy, watermarked to the buyer
Tactical Cyber Defense, Information Security & Cryptography Secure Software Development
€299 excl. VAT — EU VAT calculated at checkout (VAT ID accepted for reverse charge); invoice issued after payment
One click to Stripe — guest checkout, no account. Your download appears on the confirmation page and arrives by e-mail right after payment (link valid 72 hours, up to 5 downloads).
About this report
Cure53 is a specialised German cybersecurity services firm, founded and led by security researcher Dr.-Ing. Mario Heiderich. It offers expert vulnerability research, cryptographic system audits and penetration testing for high-reliability software and hardware systems.
Operating out of Berlin, Cure53’s team of seasoned analysts conducts hands-on security assessments across a broad range of digital platforms. Although originally established as a modest private enterprise, the company has built a reputation for uncovering deep vulnerabilities in complex systems.
Key questions this report answers
- What security services does Cure53 provide — vulnerability research, cryptographic audits and penetration testing for high-reliability systems?
- How has the Berlin firm built its reputation for uncovering deep vulnerabilities in complex systems?
- How do its assurance capabilities support European dual-use and defence software?
- What are Cure53's capability gaps, dependencies and strategic indicators?
Inside this report
- Executive Summary
- 1. Corporate Identity & Legal Structure
- 2. Strategic Business Profile
- 3. Technology Portfolio Mapping
- 4. Technology Readiness Assessment
- 5. European Strategic Program Participation
- 6. Academic & Research Origins
- 7. Dual-Use Applications & European Market Strategy
- 8. Strategic Partnerships & European Industrial Alliances
- 9. European Market Focus & Operational Domains
- 10. Intellectual Property & European Innovation Assets
- 11. Leadership & European Technical Expertise
- 12. Capability and Gap Analysis
- 13. Strategic Indicators & European Innovation Metrics
Who it's for
Investors screening Cure53, competitors and partners assessing their position, and analysts who need a sourced, structured account of the entity and its technology.
Methodology & sources
DFM reports are built from primary and official sources — TED procurement notices, CORDIS and the EU Funding & Tenders Portal, EIB operations, the NATO Innovation Fund portfolio, SIPRI data, official budget documents and company disclosures — read together with the underlying legal texts. Sources are cited in the document; the report reflects them as of its publication date (02 February 2026).
Format & delivery
14-page PDF, watermarked to you (name, e-mail, order number on every page). Delivered immediately after checkout on the confirmation page and by e-mail; the personal link is valid for 72 hours and up to 5 downloads (re-issued on request). Guest checkout — no account required. Single-user licence: see the Terms of Sale.
The full analysis, not the summary
The public briefing linked above tells you what this report found; the report itself shows the full evidence and reasoning behind it, section by section. It is the complete, dated document from the DFM research desk — sources cited, delivered as a licensed PDF you can keep and cite in your own work.
Related on DFM
More Tactical reports · Cyber Defense, Information Security & Cryptography · Secure Software Development · Free summary of this report · All reports
Prefer unlimited access?
Prefer unlimited access? Every report like this is included in the DFM Analysis subscription. See plans →